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Atypical clinical presentations associated with group 
W meningococcal disease (MenW) are well-described 
and include pneumonia, septic arthritis, endocarditis 
and epiglottitis/supraglottitis. Following anecdotal 
reports of teenagers presenting with predominantly 
gastrointestinal symptoms, we undertook a case 
review of MenW cases in 15 to 19 year-olds diagnosed 
in England between July 2015 and January 2016. Of the 
15 cases, seven presented with a short history of nau-
sea, vomiting and diarrhoea; five of these seven cases 
died within 24 hours of presentation to hospital.
The United Kingdom is currently experiencing a national 
outbreak of group W invasive meningococcal disease 
(IMD) due to rapid expansion of a single endemic 
hyper-virulent strain belonging to sequence type (ST) 
11 clonal complex (cc) [1]. Group W IMD is associated 
with atypical clinical presentations, including pneu-
monia, septic arthritis, endocarditis and epiglottitis/
supraglottitis, mainly in older adults [2]. In early 2016, 
enhanced national surveillance conducted by Public 
Health England identified two fatal group W IMD cases 
in teenagers who presented with predominantly gas-
trointestinal symptoms, prompting a review of all 15 to 
19 year-olds diagnosed with group W IMD in England in 
the current epidemiological year. Laboratory-confirmed 
cases were identified through national surveillance [1] 
and case records were rapidly reviewed on HPZone, a 
national web-based case management system used by 
health protection teams (HPTs) to record public health 
events and actions.
Case series
Between July 2015 and January 2016, 15 group W IMD 
cases were confirmed in previously-healthy 15 to 19 
year-olds (9 females, 6 males), none of whom had 
received a meningococcal ACWY (MenACWY) conjugate 
vaccine. No direct epidemiological, temporal or spatial 
links between cases were identified. Nine cases were 
confirmed by culture and eight were serotyped as 
W:2a, a surrogate marker for the hyper-virulent ST-11 cc 
(Table). For each case, all available data in the public 
health and surveillance records were retrieved retro-
spectively and summarised in the Table.
Seven teenagers (6 females, 1 male) presented pre-
dominantly with an acute (24–48 hour) history of 
gastrointestinal symptoms (nausea, vomiting and/
or abdominal pain) together with or followed by diar-
rhoea in the 24 hours before attending hospital. Two 
cases were confirmed by blood culture and subse-
quently characterised as W:2a, a surrogate marker for 
the hyper-virulent ST-11 cc; the other five were con-
firmed by PCR. Four of the seven patients had been 
reviewed either by their general practitioner (GP) or in 
the Accident and Emergency Department (A and E) on 
the first day (n=3) or second day (n=1) of illness and 
sent home with a diagnosis of gastroenteritis. A non-
blanching rash at presentation, leading to a considera-
tion of IMD in the differential diagnosis, was identified 
in only two of the seven teenagers after arrival in hos-
pital. At least two patients were isolated in a side-room 
in A and E because of diarrhoea. Five of the seven teen-
agers died. One had collapsed at home and died in A 
and E despite initial successful resuscitation. Two died 
with a presumed diagnosis of ‘gastrointestinal sepsis’ 
and ‘peritonitis’ soon after presentation to A and E and 
before they could be transferred to intensive care unit 
(ICU), while two others died in the ICU within 24 hours 
of admission. All fatal cases had multi-organ failure. A 
post-mortem report in one case noted ‘necrotic intes-
tine, shocked lung and systemic sepsis’. Of the two 
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Table
Summary of histories of laboratory-confirmed cases of invasive meningococcal disease, as well as infecting strain and 
outcomes based on public health and surveillance records, England, July 2015–January 2016 (n=15)
History and clinical 
features Initial assessment
a IMD 
suspected ICU Outcome Confirmation
b Final diagnosis
2 days D and V, stomach 
cramps lethargy, no rash
Saw GP on Day 1 and sent home 
with gastroenteritis diagnosis; 
sudden deterioration Day 2 with 
rapid progression in A and E; initially 
diagnosed with abdominal sepsis
N N Died in A and E Blood culture Septicaemia
1 day vomiting then 
diarrhoea and sore 
limbs; no rash
Saw GP on Day 1, sent home with 
gastroenteritis diagnosis; came to A 
and E later same day
N N Died in A and E PCR blood Septicaemia
1 day with D and V, 
influenza-like illness, 
and rapid deterioration
Profoundly septic with seizures on 
admission on Day 1, then became 
comatose
N Y Died in ICU next day PCR blood Septicaemia
3 days of D and 
V, headache and 
dehydration
Went to A and E on Day 2, sent home 
with gastroenteritis diagnosis; 
returned next day with rapid 
deterioration and multi-organ failure.
N Y Died in ICU same day Blood culture Septicaemia
2 days with headache 
and vomiting followed by 
1 day diarrhoea
Found collapsed at home on Day 3 
and rushed to A and E; petechial rash 
on back observed at A and E.
Y N
Cardiac 
arrest in A 
and E. Died.
PCR blood Septicaemia
1 day D and V, feverc, 
headache
Hospital admission on Day 1; initial 
blood culture and CSF meningococcal 
PCR negative; developed rash after 
hospital admission and blood sample 
subsequently sent for PCR analysis 
tested positive (reported 12 days 
after onset)
N Y Survived PCR blood Septicaemia
1 day D and V, abdominal 
pain
Saw GP on Day 1, went to A and E 
next day; hypotensive, tachycardic, 
petechiae on face
Y Y Survived PCR blood Septicaemia
Generally unwell for 1 
week; feverc, short of 
breath, general aches 
(no rash)
Presented to A and E with transient 
ischaemic attacks, developed 
pulmonary embolism
N N
Cardiac 
arrest in A 
and E. Died.
Blood culture Septicaemia
1 day of feverc, mild 
headache, nausea (no 
rash)
Admitted on Day 1 for 24 hours only; 
diagnosis confirmed by blood culture 
after discharge
N N Survived Blood culture Septicaemia
2 hours feverc, sore 
throat, stiff neck and 
headache, with purpuric 
rash
Presented directly to A and E, 
admitted to ICU but improved within 
3 days
Y N Survived CSF culture Meningitis and septicaemia
Feverc, neck pain, aches 
– improved, then had 
painful wrist joint 3 days 
later
Saw GP on Day 4 with painful wrist 
and was referred to hospital; wrist 
washed out
N N Survived PCR joint fluid Septic arthritis
3 days feverc, vomiting, 
hip and elbow joint pain
Admitted to hospital on Day 4 
and treated with IV antibiotics, no 
orthopaedic intervention
N N Survived Blood culture Septic arthritis
1 day of feverc, malaise 
and respiratory distress
Radiologically confirmed pneumonia 
on Day 1 N N Survived Blood culture Pneumonia
2 days feverc, headache, 
coryza followed by 1 day 
vomiting and coughing 
blood
Radiologically confirmed pneumonia 
on Day 3 N N Survived Blood culture Pneumonia
5 days sore throat, 
fatigue, lethargy, 
lymphadenopathy; no 
fever, no rash
Seen at hospital on Day 5 and 
blood cultures taken but was not 
hospitalised; received ambulatory IV 
antibiotics
N N Survived Blood culture Atypical
A and E: accidents and emergency department; CSF: cerebrospinal fluid; D and V: diarrhoea and vomiting; GP: general practitioner; IMD: 
invasive meningococcal disease; ICU: intensive care unit; IV: intravenous; N: no; NT: non typeable; PCR: polymerase chain reaction; Y: yes.
a Days are numbered from the day of symptom onset which is Day 1.
b All culture isolates were subsequently confirmed as W:2a, a surrogate marker for the hyper-virulent sequence type 11 clonal complex, apart 
from one patient with pneumonia (serotyped as NT/NT/NT). 
c Temperature was not reported.
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patients who survived, both had short histories of 
vomiting and diarrhoea for less than 24 hours, went 
directly to A and E and were seriously unwell at pres-
entation, requiring aggressive resuscitation and ICU 
admission.
Of the remaining eight cases (3 females, 5 males), 
seven cases were confirmed by blood (n=6) or cer-
ebrospinal fluid (n=1) culture and six were subse-
quently characterised as W:2a, a surrogate marker for 
the hyper-virulent ST-11 cc; a blood culture from one 
patient with pneumonia was serotyped as NT/NT/NT. 
Among these eight individuals, two had the more char-
acteristic clinical presentations of septicaemia – fever 
followed by rapid clinical deterioration (neither had a 
non-blanching rash) – and one died soon after present-
ing to A and E. A third teenager presented to A and E 
within hours of developing symptoms consistent with 
bacterial meningitis, was treated quickly and recovered 
without complications.
Four of the remaining five patients had other recog-
nised ‘atypical’ presentations, including septic arthri-
tis and pneumonia. The final case had non-specific 
symptoms lasting several days and no fever. This indi-
vidual was managed with intravenous antibiotics in an 
ambulatory setting and blood cultures subsequently 
confirmed the diagnosis.
Discussion
Laboratory-confirmed group W IMD cases in England 
have increased from 19 cases in the 2008/09 epide-
miological year to 176 cases in 2014/15, and its contri-
bution to total IMD cases increased from 1.7% to 24% 
of all confirmed cases, respectively [3]. This increase 
has resulted from rapid expansion of a single endemic 
hyper-virulent strain belonging to ST 11 cc, which is 
also responsible for the ongoing group W IMD out-
break in Chile and other South American countries [4]. 
In August 2015, the United Kingdom (UK) introduced 
an adolescent MenACWY conjugate vaccination pro-
gramme targeting 14 to 18 year-olds and new under-
graduate university entrants [1].
The increase in group W IMD cases was communi-
cated to clinical and public health colleagues through 
national briefing notes, peer-reviewed publications and 
online training materials (www.gov.uk/government/
collections/meningococcal-acwy-menacwy-vaccina-
tion-programme). These communications emphasised 
the high case fatality and intensive care admissions, 
and the well-described atypical clinical presentations 
– pneumonia, epiglottitis/supraglottitis and septic 
arthritis – seen in up to a quarter of cases [2]. 
Although nausea, vomiting and diarrhoea are well-
described symptoms of meningococcal disease [5] 
and are included in most public awareness leaflets 
and websites (e.g. http://www.mrfpaediatricguide.
info/diagnosis.php.html), IMD presentation with pri-
marily gastrointestinal symptoms, whilst previously 
described, is rare [6,7]. An extensive review of the lit-
erature identified only one case report in 1999 in an 80 
year-old woman who presented with fever, diarrhoea 
and abdominal pain; those authors, in turn, had only 
ascertained three previous cases in young adults in the 
literature [8]. Consequently, for the cases presented 
here, IMD was often not considered at first clinical 
assessment and public health actions, including chem-
oprophylaxis and vaccination, were, therefore, often 
delayed and by up to two weeks in one case. There 
were, however, no secondary cases identified among 
close contacts.
Interestingly, the unusual gastrointestinal presentation 
was also reported in the ongoing group W IMD outbreak 
in Chile, where 14 of 58 group W IMD cases (24%) were 
initially diagnosed as gastroenteritis and eight of these 
14 died [9]. Overall, diarrhoea was the only symptom 
that was over-represented among the 19 fatal cases 
(56% vs 27%, p = 0.034), most of whom died within a 
day of hospitalisation. Early diarrhoea and absence of 
fever are associated with poor prognosis in IMD, per-
haps due to later recognition [10,11]. 
We are currently following up all confirmed group W 
IMD cases in England and collecting more detailed 
clinical data from hospital records for cases presenting 
with predominantly gastrointestinal symptoms. We are 
aware of similar presentations in at least three young 
adults, suggesting that these findings are not confined 
to teenagers.
Conclusion
While atypical presentations such as septic arthritis, 
pneumonia, epiglottitis/supraglottitis and endocarditis 
are well-described for the less common meningococcal 
capsular groups (W and Y), clinical presentation with 
predominantly gastrointestinal symptoms – and diar-
rhoea, in particular – appears to be rare and currently 
associated with the hypervirulent ST-11 group W strain 
which, in teenagers at least, leads to rapidly progres-
sive, severe disease and high case fatality. It is hoped 
that the adolescent MenACWY vaccination programme 
will help to control group W disease in the UK. In the 
meantime, as this hypervirulent strain is still spreading 
in South America and has now been reported in other 
European countries and Australia, it is important that 
frontline clinicians and public health specialists are 
aware of this unusual but severe presentation in order 
to provide appropriate safety net advice) [12], ensure 
prompt diagnosis and early treatment of cases, and 
timely chemoprophylaxis with vaccination for close 
contacts.
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